title: The B subunit of Escherichia coli enterotoxin helps control the in vivo growth of solid tumors expressing the Epstein-Barr virus latent membrane protein 2A.
abstract: Latent membrane protein 2A (LMP2A) is expressed on almost all Epstein-Barr virus (EBV)-associated tumors and is a potential target for immunotherapeutic intervention and vaccination. However, LMP2A is not efficiently processed and presented on major histocompatibility antigens class I molecules to generate potent cytotoxic T-lymphocytes (CTL) responses capable of killing these tumors. The B subunit of Escherichia coli enterotoxin (EtxB), causes rapid internalization and processing of membrane-bound LMP2A on EBV-infected B cells, and facilitates loading of processed-LMP2A peptides onto MHC class I. This re-directed trafficking/delivery of LMP2A to the MHC class I machinery enhances recognition and killing by LMP2A-specific CTL in vitro. To test the potential of EtxB to enhance immune targeting of LMP2A expressed in solid tumors, we generated a murine tumor model (Renca-LMP2A), in which LMP2A is expressed as a transgenic neoantigen on a renal carcinoma (Renca) cell line and forms solid tumors when injected subcutaneously into BALB/c mice. The data show that in BALB/c mice which have only low levels of peripheral K(d)-LMP2A-specific CD8(+) T cells, merely a transient inhibition of tumor growth is achieved compared with naïve mice; suggesting that there is suboptimal LMP2A-specifc CTL recognition and poorly targeted tumor killing. However, importantly, treatment of these mice with EtxB led to a significant delay in the onset of tumor growth and significantly lower tumor volumes compared with similar mice that did not receive EtxB. Moreover, this remarkable effect of EtxB was achieved despite progressive reduction in tumor expression of LMP2A and MHC class I molecules. These data clearly demonstrate the potential efficacy of EtxB as a novel therapeutic agent that could render EBV-associated tumors susceptible to immune control.
authors: The Jenner Institute, Old Road Campus Research Building, Roosevelt Drive, Oxford, Oxfordshire OX3 7DQ, United Kingdom.
authors: Beatrice
authors: B
authors: Ondondo
authors: Lee
authors: L
authors: Faulkner
authors: Neil A
authors: NA
authors: Williams
authors: Andrew J
authors: AJ
authors: Morgan
authors: David J
authors: DJ
authors: Morgan
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001427:Bacterial Toxins / Q000627:therapeutic use*; D045744:Cell Line, Tumor; D004768:Enterotoxins / Q000627:therapeutic use*; D029968:Escherichia coli Proteins / Q000627:therapeutic use*; D005260:Female; D007114:Immunization; D008807:Mice, Inbred BALB C; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology; D014763:Viral Matrix Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D001427:Bacterial Toxins; C037662:EBV-associated membrane antigen, Epstein-Barr virus; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D014763:Viral Matrix Proteins; C027538:heat-labile enterotoxin, E coli
keywords: Adjuvant; Epstein-Barr virus; cytotoxic T-lymphocyte; murine
references: Immunol Cell Biol. 2007 Jul;85(5):370-7
references: 17372611
references: Vaccine. 1992;10(9):563-71
references: 1323899
references: Folia Biol (Praha). 2005;51(1):1-2
references: 15783085
references: Eur J Pediatr. 1986 Dec;145(6):550-2
references: 3028807
references: J Pathol. 2004 Jun;203(2):696-9
references: 15141385
references: Virology. 2007 Apr 10;360(2):461-8
references: 17150237
references: Front Immunol. 2013 Jul 16;4:197
references: 23874342
references: Nat Med. 2004 Sep;10(9):942-9
references: 15322536
references: Intervirology. 1993;36(1):11-9
references: 8225907
references: Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):5221-6
references: 10220447
references: J Virol. 2003 Jun;77(12):6692-9
references: 12767989
references: Infect Immun. 2001 May;69(5):3476-82
references: 11292779
references: J Immunol. 2005 Mar 15;174(6):3401-7
references: 15749873
references: Nat Rev Cancer. 2005 Apr;5(4):263-74
references: 15776005
references: Cell Mol Biol Lett. 2009;14(2):222-47
references: 19082921
references: Cell Mol Immunol. 2009 Apr;6(2):97-103
references: 19403058
references: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4675-80
references: 11296297
references: Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):226-30
references: 8552610
references: Blood. 2005 Mar 1;105(5):1898-904
references: 15542583
references: Nat Rev Cancer. 2004 Oct;4(10):757-68
references: 15510157
references: J Immunol. 2005 Oct 1;175(7):4583-92
references: 16177103
references: J Clin Oncol. 2014 Mar 10;32(8):798-808
references: 24344220
references: Mol Cell Biol. 1985 Dec;5(12):3403-9
references: 3939316
references: J Virol. 2005 Nov;79(22):13993-4003
references: 16254335
references: J Immunol. 2003 May 1;170(9):4427-31
references: 12707316
references: Virology. 2001 Oct 25;289(2):192-207
references: 11689042
references: J Immunother. 2001 Jul-Aug;24(4):363-73
references: 11565838
references: Blood. 2004 Sep 1;104(5):1482-9
references: 15150077
references: J Virol. 2001 Feb;75(4):1664-71
references: 11160664
references: J Gen Virol. 2002 May;83(Pt 5):1025-35
references: 11961256
references: Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8536-41
references: 11447291
references: J Natl Cancer Inst. 1973 Apr;50(4):1013-25
references: 4703766
references: J Immunol. 2001 Jan 15;166(2):1106-13
references: 11145691
references: Infect Immun. 2002 Jun;70(6):3249-58
references: 12011020
references: J Virol. 2004 Jan;78(2):868-81
references: 14694118
references: Blood. 2003 Mar 1;101(5):1905-12
references: 12411306
references: Nouv Presse Med. 1979 Dec 17;8(49):4031-3
references: 93275
references: J Immunol. 1982 Feb;128(2):720-5
references: 6172504
references: Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5
references: 10890896
references: Cancer Res. 2008 Apr 15;68(8):2561-3
references: 18413722
references: Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1532-7
references: 11805282
references: Transplant Proc. 1993 Feb;25(1 Pt 2):1387-8
references: 7680156
references: Int J Cancer. 1988 Oct 15;42(4):599-606
references: 2971626
references: J Virol. 2003 Apr;77(7):4298-305
references: 12634387
references: J Exp Med. 2009 Jun 8;206(6):1423-34
references: 19487422
references: Adv Exp Med Biol. 2007;597:173-87
references: 17633026